Bio-Rad Laboratories, Inc ... The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials ...

Bio-Rad Laboratories, Inc.’s BIO share price has dipped by 5.31%, which has investors questioning if this is right time to ...

In its first-quarter 2025 investor letter, Longleaf Partners Fund highlighted stocks such as Bio-Rad Laboratories, Inc. (NYSE:BIO). Bio-Rad Laboratories, Inc. (NYSE:BIO) is a life science company ...

Bio-Rad Laboratories (BIO ... A quarter ago, it was expected that this maker of instruments used in biomedical research would post earnings of $1.28 per share when it actually produced earnings ...

HERCULES, CA – Bio-Rad Laboratories, Inc. (NYSE:BIO), a manufacturer of laboratory analytical instruments with a market capitalization of $6.8 billion, announced the results of its Annual ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of Foresight™ Pro 45 cm inner diameter (ID) ...

Bio-Rad (BIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

In its first-quarter 2025 investor letter, Ariel Appreciation Fund highlighted stocks such as Bio-Rad Laboratories, Inc. (NYSE:BIO). Bio-Rad Laboratories, Inc. (NYSE:BIO) is a life science company ...

Biodesix, Inc. and Bio-Rad Laboratories have collaborated on new research findings from the ctMoniTR Project, published in Clinical Cancer Research, which demonstrate a strong connection between ...